Articles

Penn State Health Milton S. Hershey Medical Center spearheads equivalence study comparing two different types of disc replacements on the market: prodisc® C and Mobi-C®.
Continuing a trend of adding less invasive therapeutic options to its spine surgeons’ armamentarium, the Penn State Health Spine Center at Penn State Health Milton S. Hershey Medical Center now offers the OsteoCool RF Ablation System by Medtronic, a treatment that allows surgeons to palliate painful spinal metastases with radiofrequency (RF) ablation and stabilize the spine during the same procedure.
Prior to 2013, Penn State Children’s Hospital’s patients and families shared space with the adult hospital on the campus of Penn State Milton S. Hershey Medical Center. A three-story addition to the standalone Children’s Hospital that opened in 2013 — slated to be complete in November 2020 — will bring all children’s services into the Penn State Children’s Hospital, including a larger neonatal intensive care unit as well as the Labor and Delivery unit and postpartum patient rooms for women.
U.S. News & World Report ranks Penn State Children’s Hospital’s Pediatric Nephrology division as 48th in America.
Hematology services within the Penn State Children’s Hospital’s Division of Pediatric Hematology and Oncology adds a key layer of expertise to the diagnosis and treatment of children with blood disorders.
Safety, innovation and collaboration positions Penn State Children’s Hospital as a leader in providing neonatal care — even during a worldwide health crisis.
Founded on research, the Penn State Children’s Hospital NICU marshals innovation to provide optimal outcomes for its smallest patients.
Penn State Health OnDemand offers social distancing options for individuals in need of medical services.
The Penn State Health Spine Center at Penn State Health Milton S. Hershey Medical Center is transforming spine surgery in central Pennsylvania with the Mazor X Stealth Edition by Medtronic, a robotic guidance system that allows neurosurgeons to plan and execute open and minimally invasive spine surgeries with unprecedented accuracy, producing a bevy of benefits for patients.
Advanced cerebrovascular and endovascular surgical techniques and technology for complex cases bring patients in central Pennsylvania new hope.
Through pointed research efforts that aim to improve patient outcomes and quality of life, the Department of Neurosurgery at Penn State Health Milton S. Hershey Medical Center provides central Pennsylvania and surrounding counties with leading-edge surgical treatments for a variety of neurological conditions.
Penn State Health St. Joseph Cancer Center uses genetic evaluation to determine patients’ cancer risk and provide actionable next steps through their Cancer Risk Evaluation Program (CREP).
Colorectal cancer is the second-leading cause of cancer death in central Pennsylvania, which is partially attributable to low screening rates among certain segments of the population. Penn State Cancer Institute researchers are developing and testing strategies to improve screening rates in order to diagnose and treat colorectal cancer in earlier stages, when treatment efficacy is generally optimized.
Andrews Patel Hematology/Oncology has been providing central Pennsylvania residents access to high-level cancer care for more than 30 years and is now doing even more as part of Penn State Health.
True to its rich history of innovation, Penn State Heart and Vascular Institute at Penn State Health Milton S. Hershey Medical Center offers advanced therapies available only through clinical trials — treatments in the vanguard of care that can improve quality of life while laying the groundwork to help untold numbers of patients enjoy a brighter future.
Treatment of skull base tumors, including those affecting the pituitary gland, traditionally entailed opening the skull or making large incisions in the face and removing parts of the facial bones. These invasive procedures caused significant pain and scarring and required long hospital stays.
Penn State Health Milton S. Hershey Medical Center is one of eight academic medical centers nationwide taking part in a clinical trial of Cxbladder — a noninvasive test that could spare thousands of patients the pain and expense involved in evaluating a diagnosis of hematuria.
Patients with a noninvasive, low-grade form of bladder cancer often need multiple surgeries to treat recurrences, which are common. A new chemoablative gel currently under study at Penn State Health may eliminate the need for those procedures.
A team of experienced pediatricians and support staff in the Pediatric Complex Care program at Penn State Children’s Hospital collaborates to deliver advanced treatments to patients with multiple chronic illnesses, improving outcomes while helping families overcome socioeconomic and other barriers to care.
Uniting high-level prenatal and surgical care with comprehensive support services, the Perinatal Program at Penn State Health Milton S. Hershey Medical Center and Penn State Children’s Hospital has become the regional referral center for diagnosis and treatment of suspected fetal anomalies.